aspartic acid has been researched along with Infections, Klebsiella in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aanensen, DM; Beis, K; Brett, SJ; Clements, A; David, S; Frankel, G; Giani, T; Kwong, HS; Low, WW; Morecchiato, F; Rossolini, GM; Sanchez-Garrido, J; Wong, JLC | 1 |
| Bai, Y; Guo, Q; Lei, X; Song, F; Wang, S; Wei, Q; Yang, S; Zhang, J; Zhang, L | 1 |
| Akinbi, HT; Ballard, TN; Nash, JA; Weaver, TE | 1 |
3 other study(ies) available for aspartic acid and Infections, Klebsiella
| Article | Year |
|---|---|
Widespread emergence of OmpK36 loop 3 insertions among multidrug-resistant clones of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Aspartic Acid; Bacterial Proteins; beta-Lactamases; Clone Cells; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins | 2022 |
Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
Topics: Aspartic Acid; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2017 |
The peptidoglycan-degrading property of lysozyme is not required for bactericidal activity in vivo.
Topics: Animals; Aspartic Acid; Blood Bactericidal Activity; Bronchoalveolar Lavage Fluid; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Knockout; Mice, Transgenic; Muramidase; Mutagenesis, Site-Directed; Peptidoglycan; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Respiratory Mucosa; Serine; Staphylococcal Infections; Staphylococcus aureus | 2006 |